Protocol Ledger

NCT07771465 · Phase III · RECRUITING

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Interventional Phase III clinical trial protocol NCT07771465 sponsored by Kardigan in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-26 Enrollment: 332 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07771465
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)332 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07771465
Protocol FieldVerified Registry Value
NCT IdentifierNCT07771465
Consolidated Lead SponsorKardigan
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment332 participants (ESTIMATED)
Registered Start Date2026-08-26
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI